Exchange: NYSE·Updated 04:16 PM EDT

STE News

News
all
press releases
Reasons to Add STE Stock to Your Portfolio Right Now
STERIS' strong Healthcare growth, improving AST prospects and rising Life Sciences demand bolster its outlook, despite tariff and inflationary pressures.
Zacks
Reasons to Add STE Stock to Your Portfolio Right Now
STERIS' strong Healthcare growth, improving AST prospects and rising Life Sciences demand bolster its outlook, despite tariff and inflationary pressures.
Zacks
More News
Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)
Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE) Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)PR NewswirePITTSBURGH, Oct. 12, 2026PITTSBURGH, Oct. 12, 2026 /PRNewswire/ -- Xodus Medical, a leading developer and manufacturer of innovative surgical...
PR Newswire
Full Transcript: Steris Q1 2027 Earnings Call
Steris (NYSE:STE) held its first-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and transcripts,read more...
Benzinga
Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?
STE is betting $600 million on a new chemistry center to boost capacity and efficiency, but higher spending and execution risks loom.
Zacks
Should Investors Buy STERIS as Growth Meets Reasonable Valuation?
STE enters fiscal 2027 with solid growth, recurring healthcare demand and better margins, but tariffs and investment needs temper the valuation case.
Zacks
Ecolab Rallies 12.2% in 3 Months as High-Tech Growth Gains Momentum
ECL's 12.2% three-month rally is backed by High-Tech, Digital and Life Sciences growth, firmer pricing and a higher 2026 earnings outlook.
Zacks
STE Q1 Earnings Beat, Revenues Miss, Stock Dips in Aftermarket Trading
STERIS beats fiscal Q1 earnings estimates as sales rise 7.3%, but a modest revenue miss sends shares 2.4% lower after hours.
Zacks
5 Quality Stocks Set to Reward Investors With Dividend Hikes
Recent dividend hikes from DRH, STE, BCC, KWR and WHD highlight financially solid companies as investors seek stability in a mixed market.
Zacks
Here's What Key Metrics Tell Us About Steris (STE) Q1 Earnings
While the top- and bottom-line numbers for Steris (STE) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks

Advertisement|Remove ads.